Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Biote (BTMD) Long-Term Investments (2021 - 2022)

Biote has reported Long-Term Investments over the past 2 years, most recently at $317.6 million for Q1 2022.

Quarterly results put Long-Term Investments at $317.6 million for Q1 2022, changed 0.02% from a year ago — trailing twelve months through Mar 2022 was $317.6 million (changed 0.02% YoY), and the annual figure for FY2021 was $317.6 million, changed.
Long-Term Investments for Q1 2022 was $317.6 million at Biote, roughly flat from $317.6 million in the prior quarter.
Over the last five years, Long-Term Investments for BTMD hit a ceiling of $317.6 million in Q1 2022 and a floor of $317.5 million in Q2 2021.